Mackay Shields’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Mackay Shields's AMGN Position: Q2 2022 in Review
Mackay Shields sold out of Amgen (AMGN) in Q2 2022, closing a stake of 81,415 shares — an estimated $19.7M sold.
Mackay Shields first reported a position in AMGN in Q1 2018 and held it in 16 quarters. The position peaked at $62M in Q4 2019. 2,354 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.
- Mackay Shields reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
- Mackay Shields sold 81,415 Amgen shares in Q2 2022, an estimated $19.7M.
- Mackay Shields first reported a position in Amgen in Q1 2018 and held it in 16 quarters.
- Mackay Shields's Amgen position peaked at $62M in Q4 2019.
- 2,354 funds tracked by Wall St. Rank held Amgen as of Q2 2022.
Based on Mackay Shields's 13F filing for Q2 2022, filed 3 Aug 2022.